Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D4 Lymphadenectomy for Gastric Cancer
NCT02423278Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2010
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Overall Survival at 5 years and Relapse-free Survival at 5 years. Status: unknown.
Beyond the preview
Go deeper on NCT02423278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423278.